State UT
Clinical Trials in Utah
Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 211 actively recruiting studies with Utah sites out of 211 registered in total. The busiest research areas in Utah are Breast Cancer, Prostate Cancer, Ovarian Cancer. Leading sponsors running trials in the state include University of Utah, National Cancer Institute (NCI), Eli Lilly and Company. By stage, Utah trials break down as Phase 1 (42), Phase 2 (65), Phase 3 (71), Phase 4 (5).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Utah
Frequently Asked Questions — Clinical Trials in Utah
How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 211 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 211. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Prostate Cancer, Ovarian Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Utah
NCT06568562 Phase 2
Recruiting
XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
Condition
Metastatic Castration-resistant Prostate Cancer
Enrollment
32 pts
Location
United States
Sponsor
University of Utah
NCT05201144 Phase 2
Recruiting
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic He...
Condition
Congenital Diaphragmatic Hernia
Enrollment
40 pts
Location
United States
Sponsor
University of Utah
NCT07511816 Phase 2
Recruiting
A Study of LY4515100 in Participants With Pain Following Third Molar Removal
Condition
Acute Pain
Enrollment
212 pts
Location
United States
Sponsor
Eli Lilly and Company
NCT07417111 N/A
Recruiting
Continued Pressure for Alveolar Protection (CPAP Trial)
Condition
Bronchopulmonary Dysplasia (BPD)
Enrollment
860 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
NCT07023614 Phase 2
Recruiting
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Sy...
Condition
Non-obstructive Hypertrophic Cardiomyopathy
Enrollment
165 pts
Location
United States, Austria, Belgium
Sponsor
Imbria Pharmaceuticals, Inc.
NCT06003192 N/A
Recruiting
Screen Smart: Using Digital Health to Improve HIV Screening and Prevention
Condition
HIV Infections
Enrollment
63,000 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT07015905 Phase 3
Recruiting
REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee ...
Condition
Venous Thromboembolism (VTE)
Enrollment
2,000 pts
Location
United States, Bulgaria, Hungary
Sponsor
Regeneron Pharmaceuticals
NCT07718581 Phase 1, Phase 2
Recruiting
HMPL-A830 in Solid Tumors
Condition
Solid Tumor, Adult
Enrollment
147 pts
Location
United States, China
Sponsor
Hutchmed
NCT06283966 Phase 3
Recruiting
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fum...
Condition
COPD (Chronic Obstructive Pulmonary Disease)
Enrollment
5,250 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT04743765 N/A
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
Condition
Hip Fractures
Enrollment
1,100 pts
Location
United States, Australia, Belgium
Sponsor
Population Health Research Ins
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
NCT07630974 Phase 1, Phase 2
Recruiting
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
134 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT07329283 N/A
Recruiting
Nighttime Synchrony of Your Nutrition and Circadian Health
Condition
Sleep
Enrollment
120 pts
Location
United States
Sponsor
University of Utah
NCT06701669 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Parid...
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
200 pts
Location
United States
Sponsor
PPD Development, LP
NCT07361562 Phase 1
Recruiting
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Soli...
Condition
Advanced Solid Tumor, Adult
Enrollment
100 pts
Location
United States
Sponsor
Cogent Biosciences, Inc.
NCT06772623 Phase 1, Phase 2
Recruiting
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab ...
Condition
Non Small Cell Lung Carcinoma
Enrollment
252 pts
Location
United States, Argentina, Australia
Sponsor
AbbVie
NCT06804824 Phase 1
Recruiting
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-1596...
Condition
Advanced Solid Tumors
Enrollment
220 pts
Location
United States, Australia
Sponsor
Vividion Therapeutics, Inc.
NCT07470853 Phase 1
Recruiting
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With A...
Condition
PROC
Enrollment
265 pts
Location
United States
Sponsor
Whitehawk Therapeutics, Inc.
NCT07780669 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Com...
Condition
Pulmonary Disease, Chronic Obstructive
Enrollment
624 pts
Location
United States, Japan
Sponsor
GlaxoSmithKline
NCT05826925 N/A
Recruiting
Optimizing Cardiovascular Preventive Care for Women Following Hypertensive Disor...
Condition
Hypertension, Pregnancy Induced
Enrollment
30 pts
Location
United States
Sponsor
University of Utah
NCT05763251 N/A
Recruiting
Comparison of Uncomplicated Candidemia Therapy Duration in Children and Adults
Condition
Invasive Candidiasis
Enrollment
420 pts
Location
United States, Australia
Sponsor
Arkansas Children's Hospital R
NCT06874335 Phase 1
Recruiting
A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
Condition
Solid Tumor
Enrollment
140 pts
Location
United States
Sponsor
Biohaven Therapeutics Ltd.
NCT06790693 Phase 3
Recruiting
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor a...
Condition
Breast Cancer
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT06330064 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in ...
Condition
Recurrent or Metastatic Solid Tumors
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Daiichi Sankyo
NCT07518186 Phase 3
Recruiting
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or ...
Condition
Multiple Myeloma
Enrollment
700 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology